Cardiovascular comorbidities in acromegaly: an update on their diagnosis and management

Ana M Ramos-Leví1, Mónica Marazuela2

  • 1Department of Endocrinology, Hospital Universitario La Princesa, Instituto de Investigación Princesa, Universidad Autónoma, Madrid, Spain.

Endocrine
|January 3, 2017
PubMed

Insights

Acromegaly frequently causes cardiovascular comorbidities like hypertension and cardiomyopathy, increasing mortality risk. Early screening and treatment are crucial for managing these heart conditions in acromegaly patients.

Area of Science:

  • Endocrinology
  • Cardiology
  • Internal Medicine

Background:

  • Cardiovascular comorbidities are highly prevalent in acromegaly patients.
  • These conditions significantly increase morbidity and all-cause mortality.
  • Common findings include hypertension, cardiomyopathy, arrhythmias, and coronary artery disease.

Purpose of the Study:

  • To review prevalent cardiovascular comorbidities in acromegaly.
  • To discuss their underlying pathophysiology.
  • To provide recommendations for diagnosis, management, and treatment.

Main Methods:

  • Literature review of cardiovascular complications in acromegaly.
  • Discussion of physiopathological factors including growth hormone/insulin-like growth factor 1 excess.
  • Analysis of diagnostic techniques and treatment effects.

Main Results:

  • Cardiovascular comorbidities are frequent and multifactorial in acromegaly.
  • Uncontrolled hormone excess, age, and disease duration are key influences.
  • Prompt diagnosis and management can mitigate cardiac abnormalities.

Conclusions:

  • Cardiovascular health is a critical concern in acromegaly management.
  • A systematic approach to screening and treatment is recommended.
  • Further understanding of diagnostic tools and therapeutic impacts is needed.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...